{"nctId":"NCT00515879","briefTitle":"Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia","startDateStruct":{"date":"2007-12"},"conditions":["Social Anxiety Disorder"],"count":169,"armGroups":[{"label":"CBT plus d-cycloserine","type":"EXPERIMENTAL","interventionNames":["Drug: D-cycloserine","Behavioral: Cognitive behavioral therapy (CBT)"]},{"label":"CBT plus placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Behavioral: Cognitive behavioral therapy (CBT)","Drug: Placebo"]}],"interventions":[{"name":"D-cycloserine","otherNames":["Seromycin"]},{"name":"Cognitive behavioral therapy (CBT)","otherNames":[]},{"name":"Placebo","otherNames":["Sugar pill"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Meets DSM-IV criteria for generalized social anxiety disorder (GSAD)\n* Total score of greater than or equal to 60 on the LSAS\n* Physical examination, electrocardiogram, and laboratory findings without clinically significant abnormalities\n\nExclusion Criteria:\n\n* Lifetime history of bipolar disorder, schizophrenia, psychosis, delusional disorders, or obsessive-compulsive disorder\n* Eating disorder within the 6 months prior to study entry\n* History of organic brain syndrome, mental retardation, or other cognitive dysfunction\n* Substance or alcohol abuse or dependence (other than nicotine) within the 6 months prior to study entry or inability to refrain from alcohol use during the acute period of study participation\n* Post-traumatic stress disorder within 6 months prior to study entry; entry of patients with other mood or anxiety disorders will be permitted if the social anxiety disorder is judged to be the predominant disorder\n* Suicidal thoughts\n* Taking concurrent psychotropic medication (e.g., antidepressants, anxiolytics, beta blockers) within 2 weeks of study entry\n* Significant personality dysfunction\n* Serious medical illness or instability for which hospitalization may be likely within the next year","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Social Phobic Disorders Severity and Change Form","description":"Social Phobic Disorders Severity and Change Form (SPD-SC Form; Liebowitz et al., 1992) is an expansion and adaptation of the Clinical Global Impression Scale (CGI) by Guy (1976) to SAD. Similar to the original CGI scale, the SPD-SC Form is rated by an independent evaluator on a 7-point scale to indicate severity (1=normal/not ill; 2 = minimally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most severely ill) and improvement (1=very much improved; 2=much improved; . 3=minimally improved' 4 = no change; 5=nimimal deterioration; 6=severe deterioration; 7=very severe deterioration). The primary outcome measure is units of a scale ranging from 1 (very much improved) to 7 (very severe deterioration).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.68","spread":null},{"groupId":"OG001","value":"2.95","spread":null}]}]}]},{"type":"PRIMARY","title":"Liebowitz Social Anxiety Scale (LSAS)","description":"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations; it is widely used in treatment studies of SAD. Total scores range from 0 (no anxiety) to 144 (maximum).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.19","spread":null},{"groupId":"OG001","value":"42.44","spread":null}]}]}]},{"type":"SECONDARY","title":"Social Phobia and Anxiety Inventory","description":"The Social Phobia and Anxiety Inventory (SPAI; Turner, Beidel, Dancu, and Stanley, 1989) is a 45-item self-report measure on the frequency (0 = Never, 1 = Very Infrequent, 2 = Infrequent, 3 = Sometimes, 4 = Frequent, 5 = Very Frequent, 6 = Always) of one's experiences. The inventory includes 32 items assessing somatic, cognitive, and behavioral symptoms of social anxiety and 13 items assessing agoraphobia. The final score is calculated by subtracting the agoraphobia subscale total (max = 78; min = 0) from the social phobia subscale total (max = 192; min = 0). Thus, the final total scores range from 0-114, where higher final scores indicate higher social anxiety.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"71.08","spread":"28.585"},{"groupId":"OG001","value":"73.74","spread":"30.311"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.64","spread":"32.188"},{"groupId":"OG001","value":"71.97","spread":"30.566"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.67","spread":"31.847"},{"groupId":"OG001","value":"67.74","spread":"33.289"}]}]}]},{"type":"SECONDARY","title":"Quality of Life Enjoyment and Satisfaction Questionnaire","description":"The Quality of Life Enjoyment and Satisfaction Questionnaire (Endicott et al., 1993) is a 16-item self-report measure that rates aspects of quality of life, including physical health, mood, activities of daily living, and overall life satisfaction. Responses are scored on a 5 point scale. The maximum score is 70 (high satisfaction) and the minimum is 14 (low satisfaction); scores are generally expressed as a percentage of maximum total score (0-100).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.77","spread":"14.075"},{"groupId":"OG001","value":"67.44","spread":"14.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.32","spread":"16.066"},{"groupId":"OG001","value":"67.44","spread":"14.872"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.08","spread":"16.063"},{"groupId":"OG001","value":"69.58","spread":"11.761"}]}]}]},{"type":"SECONDARY","title":"Liebowitz Self-Rated Disability Scale","description":"Liebowitz Self-Rated Disability Scale (Schneier et al., 1994) is an 11-item scale assessing impairment specific to social anxiety. Current (past 2 weeks) and most severe lifetime impairment due to social anxiety disorder are rated on a 0-3 scale of degree of limitation (0=problem does not limit me at all; 3=problem limits me severely). The maximum score is 44 (severe impairment) and the minimum is 0 (no impairment).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.6117","spread":"7.25681"},{"groupId":"OG001","value":"14.0303","spread":"7.79688"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.5283","spread":"7.03686"},{"groupId":"OG001","value":"14.4977","spread":"7.98470"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.3269","spread":"7.72461"},{"groupId":"OG001","value":"14.3130","spread":"7.62630"}]}]}]},{"type":"SECONDARY","title":"Range of Impaired Functioning Tool","description":"The Range of Impaired Functioning Tool (LIFE-RIFT, Leon et al., 2000) is a clinician rated scale assessing functioning in four domains: work, interpersonal relationships, recreation, and global satisfaction. Each domain is scored 0-5 (0=not applicable, 1=no impairment, 2=slight impairment, 3=mild impairment, 4=moderate impairment, 5=severe impairment). The total score is the sum of each domain's score, with a maximum score of 20 (severe impairment) and a minimum score of 4 (no impairment).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.5256","spread":"2.780"},{"groupId":"OG001","value":"8.6667","spread":"2.80841"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.6143","spread":"2.67730"},{"groupId":"OG001","value":"8.5430","spread":"2.82987"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.6232","spread":"2.80284"},{"groupId":"OG001","value":"7.7458","spread":"2.43957"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":87},"commonTop":[]}}}